ATE252546T1 - 3-(3-hydroxyphenyl)-3-amino-propionamidderivate - Google Patents

3-(3-hydroxyphenyl)-3-amino-propionamidderivate

Info

Publication number
ATE252546T1
ATE252546T1 AT00304372T AT00304372T ATE252546T1 AT E252546 T1 ATE252546 T1 AT E252546T1 AT 00304372 T AT00304372 T AT 00304372T AT 00304372 T AT00304372 T AT 00304372T AT E252546 T1 ATE252546 T1 AT E252546T1
Authority
AT
Austria
Prior art keywords
hydroxyphenyl
amino
propionamide derivatives
compounds
propionamide
Prior art date
Application number
AT00304372T
Other languages
English (en)
Inventor
Spiros Liras
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of ATE252546T1 publication Critical patent/ATE252546T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
AT00304372T 1999-05-28 2000-05-24 3-(3-hydroxyphenyl)-3-amino-propionamidderivate ATE252546T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13654899P 1999-05-28 1999-05-28

Publications (1)

Publication Number Publication Date
ATE252546T1 true ATE252546T1 (de) 2003-11-15

Family

ID=22473319

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00304372T ATE252546T1 (de) 1999-05-28 2000-05-24 3-(3-hydroxyphenyl)-3-amino-propionamidderivate

Country Status (9)

Country Link
EP (1) EP1055665B1 (de)
JP (1) JP3627975B2 (de)
AT (1) ATE252546T1 (de)
BR (1) BR0002507A (de)
CA (1) CA2309439C (de)
DE (1) DE60006032T2 (de)
DK (1) DK1055665T3 (de)
ES (1) ES2206139T3 (de)
PT (1) PT1055665E (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6838580B2 (en) * 2002-01-29 2005-01-04 Teikoku Seiyaku Co., Ltd. Opioid derivative
DK2653465T3 (da) * 2004-03-15 2016-08-22 Janssen Pharmaceutica Nv Opioid-receptormodulatorer
AU2013205089B2 (en) * 2004-03-15 2013-12-19 Janssen Pharmaceutica, N.V. Novel compounds as opioid receptor modulators
AU2006223482A1 (en) * 2005-03-14 2006-09-21 Janssen Pharmaceutica, N.V. Process for the preparation of opioid modulators
CN112867705A (zh) * 2018-04-04 2021-05-28 埃皮欧黛公司 阿片样物质受体调节剂以及与其相关的产品和方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5272175A (en) * 1992-05-20 1993-12-21 G. D. Searle & Co. Substituted tyrosyl diamide compounds
US5389645A (en) * 1992-08-13 1995-02-14 G. D. Searle & Co. Substituted tyrosyl diamine amide compounds
WO1996022276A1 (fr) * 1995-01-20 1996-07-25 Nippon Shinyaku Co., Ltd. Derives d'ethylamine et medicaments

Also Published As

Publication number Publication date
DE60006032D1 (de) 2003-11-27
DK1055665T3 (da) 2004-03-01
CA2309439C (en) 2004-10-05
PT1055665E (pt) 2004-03-31
CA2309439A1 (en) 2000-11-28
BR0002507A (pt) 2003-01-28
EP1055665A1 (de) 2000-11-29
ES2206139T3 (es) 2004-05-16
DE60006032T2 (de) 2004-06-17
EP1055665B1 (de) 2003-10-22
JP3627975B2 (ja) 2005-03-09
JP2000351756A (ja) 2000-12-19

Similar Documents

Publication Publication Date Title
PT1259489E (pt) Compostos azapoliciclicos condensados con arilo.
CA2343236A1 (en) 4,4-biarylpiperidine derivatives
DE60003863D1 (de) Dioxocyclopentylhydroxamsäure
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
DE60219954D1 (de) Neue Indol-2-on Derivate
DK0842934T3 (da) 5-HT1F agonister
PT992509E (pt) Novos derivados macrolidos
AP2001002191A0 (en) 3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives.
ATE252546T1 (de) 3-(3-hydroxyphenyl)-3-amino-propionamidderivate
ID25478A (id) Agonis 5-ht1f
CA2299036A1 (en) 4-phenyl-4-heteroarylpiperidine derivatives
EP1057829A4 (de) Kondensierte Pyrimidinderivate und diese enthaltende pharmazeutische Zubereitungen
ATE283269T1 (de) 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems
BR0210749A (pt) Composições de fragrância e sabor
ATE334977T1 (de) Discodermolid-analoga und ihre pharmazeutische verwendung
BR9900024A (pt) Biciclo[3.1.0]hexanos e compostos relacionados.
PT952157E (pt) Derivados 9a, 11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina
ECSP993220A (es) Derivados de 3,3- biarilpiperidina y 2,2 - biarilmorfolina

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1055665

Country of ref document: EP

REN Ceased due to non-payment of the annual fee